Component: (Network and Table)
Network
00100 - Statement - Consolidated Balance Sheets
(http://www.amicustherapeutics.com/role/StatementConsolidatedBalanceSheets)
Table(Implied)
Slicers (applies to each fact value in each table cell)
Reporting Entity [Axis]0001178879 (http://www.sec.gov/CIK)
Consolidated Balance SheetsPeriod [Axis]
2016-12-31
2015-12-31
Consolidated Balance Sheets
 
 
Assets:
 
 
Current assets:
 
 
Cash and cash equivalents
187,026,000  
69,485,000  
Investments in marketable securities
143,325,000  
144,548,000  
Accounts receivable
1,304,000  
 
Inventories
3,416,000  
0  
Prepaid expenses and other current assets
4,993,000  
2,568,000  
Total current assets
340,064,000  
 
216,601,000  
 
Property and equipment, less accumulated depreciation of $12,495 and $13,353 at December 31, 2016 and 2015, respectively
9,816,000  
6,178,000  
In-process research & development
486,700,000  
486,700,000  
Goodwill
197,797,000  
197,797,000  
Other non-current assets
2,468,000  
1,108,000  
Total Assets
1,036,845,000  
 
908,384,000  
 
Liabilities and Stockholders' Equity
 
 
Current liabilities:
 
 
Accounts payable, accrued expenses , and other current liabilities
41,008,000  
32,216,000  
Deferred reimbursements, current portion
13,850,000  
 
Contingent consideration payable, current portion
56,101,000  
41,400,000  
Total current liabilities
110,959,000  
 
73,616,000  
 
Deferred reimbursements
21,906,000  
35,756,000  
Convertible notes
154,464,000  
 
Due to related party
 
41,601,000  
Contingent consideration payable
213,621,000  
232,677,000  
Deferred income taxes
173,771,000  
176,219,000  
Other non-current liability
1,973,000  
681,000  
Commitments and contingencies
xsi:nil  
xsi:nil  
Stockholders' equity:
 
 
Common stock, $.01 par value, 250,000,000 shares authorized, 142,691,986 shares issued and outstanding at December 31, 2016 Common stock, $.01 par value, 250,000,000 shares authorized, 125,027,034 shares issued and outstanding at December 31, 2015
1,480,000  
1,306,000  
Additional paid-in capital
1,120,156,000  
917,454,000  
Accumulated other comprehensive loss:
 
 
Foreign currency translation adjustment, less tax benefit of $1,293 at December 31, 2016
1,945,000  
 
Unrealized gain/(loss) on available-for securities
102,000  
(115,000) 
Warrants
16,076,000  
8,755,000  
Accumulated deficit
(779,608,000) 
(579,566,000) 
Total stockholders' equity
360,151,000  
 
347,834,000  
 
Total Liabilities and Stockholders' Equity
1,036,845,000  
 
908,384,000